|
Market Closed -
NYSE
04:02:53 2026-10-07 pm EDT
|
5-day change | 1st Jan Change | ||
| 98.73 USD | +0.58% |
|
-2.20% | -21.20% |
| Oct. 07 | Barclays Initiates Coverage on Abbott Laboratories With Overweight Rating, $120 Price Target | MT |
| Oct. 05 | Abbott Laboratories Receives FDA Approval for New CardioMEMS HF System capabilities | CI |
| Market Cap | 170B 152B 141B 129B 242B 16,435B 244B 1,699B 663B 8,355B 638B 624B 26,838B | P/E 2026 * |
28.7x | P/E 2027 * | 22.3x |
|---|---|---|---|---|---|
| Enterprise Value | 194B 173B 161B 147B 276B 18,751B 278B 1,939B 757B 9,533B 728B 712B 30,621B | EV / Sales 2026 * |
3.86x | EV / Sales 2027 * | 3.5x |
| Free-Float |
86.16% | Yield 2026 * |
2.62% | Yield 2027 * | 2.79% |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| ABT | Delayed | |
CBOE
| ABT | Real-time | |
|
London S.E.
| ABT | Delayed | |
|
Tradegate
| ABL | Real-time | |
|
Xetra
| ABL | Delayed | |
|
Boerse Muenchen
| ABL | Real-time | |
|
Deutsche Boerse AG
| ABL | Delayed | |
|
Borsa Italiana
| 1ABT | End-of-day quote | |
|
CBOE
| Real-time | ||
|
CBOE
| ABT | Real-time | |
|
Mexican S.E.
| ABT * | End-of-day quote | |
|
Börse Stuttgart
| ABL | Delayed | |
|
Kazakhstan S.E.
| ABT_KZ | End-of-day quote | |
|
Lima
| ABTUS | End-of-day quote | |
|
Swiss Exchange
| ABT | Delayed | |
|
Wiener Boerse
| ABT | End-of-day quote | |
|
Santiago S.E.
| ABTCL | End-of-day quote | |
|
Santiago S.E.
| ABT | End-of-day quote |
Last Transcript: Abbott Laboratories
| 1 day | +0.58% | ||
| 1 week | -2.20% | ||
| Current month | -0.10% | ||
| 1 month | -8.86% | ||
| 3 months | +3.24% | ||
| 6 months | -3.49% | ||
| Current year | -21.20% |
| 1 week | 95.06 |  | 100.95 |
| 1 month | 95.06 | | 108.39 |
| Current year | 81.97 | | 129.46 |
| 1 year | 81.97 | | 135.12 |
| 3 years | 81.97 | | 141.23 |
| 5 years | 81.97 | | 142.6 |
| 10 years | 37.38 | | 142.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Ford
CEO | Chief Executive Officer | 52 | 2020-03-30 |
Philip Boudreau
DFI | Director of Finance/CFO | 53 | 2023-08-31 |
Sabina Ewing
CIO | Chief Investment Officer | 51 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Sally Blount
BRD | Director/Board Member | 64 | 2011-12-08 |
Nancy McKinstry
BRD | Director/Board Member | 67 | 2011-12-08 |
Daniel Starks
BRD | Director/Board Member | 71 | 2017-02-15 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/30/26 | Free | Director | 333 | 0.0000% | ||
| 9/30/26 | Free | Director | 318 | 0.0000% | ||
| 9/30/26 | Free | Director | 381 | 0.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.58% | -2.20% | -26.18% | +1.91% | 170B | |
| -1.81% | -1.81% | -13.13% | +12.34% | 111B | |
| -1.01% | -1.21% | -24.81% | +3.59% | 107B | |
| -0.03% | +1.42% | -46.89% | -10.61% | 75.95B | |
| +0.28% | +3.14% | +3.91% | +72.56% | 60.37B | |
| -0.65% | +6.59% | +11.44% | +66.40% | 53.53B | |
| -0.08% | -0.99% | -6.16% | -31.35% | 49.11B | |
| -1.70% | -5.02% | -19.29% | +13.61% | 40.6B | |
| +1.09% | -2.70% | +27.03% | +1.30% | 31.47B | |
| -0.28% | +1.34% | - | - | 31.19B | |
| Average | -0.07% | +0.38% | -10.45% | +14.42% | 73.02B | |
| Weighted average by Cap. | +0.06% | +0.03% | -16.46% | +11.82% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 50.2B 44.82B 41.81B 37.99B 71.56B 4,857B 72.09B 502B 196B 2,469B 188B 184B 7,932B | 54.53B 48.68B 45.42B 41.26B 77.73B 5,276B 78.3B 546B 213B 2,682B 205B 200B 8,616B |
| Net income | 6.21B 5.55B 5.17B 4.7B 8.86B 601B 8.92B 62.16B 24.25B 306B 23.32B 22.82B 982B | 7.89B 7.05B 6.57B 5.97B 11.25B 764B 11.34B 78.98B 30.82B 388B 29.63B 28.99B 1,247B |
| Net Debt | 23.94B 21.37B 19.94B 18.12B 34.13B 2,316B 34.38B 240B 93.47B 1,178B 89.87B 87.92B 3,783B | 20.96B 18.71B 17.46B 15.86B 29.87B 2,028B 30.1B 210B 81.82B 1,031B 78.68B 76.97B 3,311B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-07 | $98.73 | +0.58% | 9,031,117 |
| 26-10-06 | $98.16 | -1.94% | 10,577,127 |
| 26-10-05 | $100.10 | +2.67% | 11,988,857 |
| 26-10-02 | $97.50 | +0.84% | 8,709,933 |
| 26-10-01 | $96.69 | -2.17% | 8,862,865 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ABT Stock
Select your edition
All financial news and data tailored to specific country editions
